A group of probes for detecting HPV high-risk and intermediate-risk nucleic acids, detection kits and applications thereof
A kit, medium-risk technology, applied in the field of molecular detection, can solve problems such as loss of probe function
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0060] Example 1 A preferred embodiment of a kit for detecting HPV high-risk and intermediate-risk nucleic acid molecular levels of the present invention
[0061] The kit of this embodiment contains HPV double FAM-labeled probes, streptavidin-labeled microspheres, pre-hybridization solution, hybridization solution, washing solution and probes.
[0062] Wherein, the probe is a probe for detecting high-risk and intermediate-risk HPV nucleic acids, and the probe is at least one of the sequences shown in SEQ ID NO: 1-28. The sequence shown in SEQ ID NO:1-28 is specifically as follows:
[0063] HPV-1:5'-ACGTGTTCTTGATGATCTGC-3'
[0064] HPV-2:5'-TAGAGATCAGTTGTCTCTGG-3'
[0065] HPV-3:5'-TGTAGAGTCACACTTRCAACA-3'
[0066] HPV-4:5'-TGTGTGCTTTGTACGCACAA-3'
[0067] HPV-5:5'-GGTCTTCCAAAGTACGAATG-3'
[0068] HPV-6:5'-ATTCCTAGTGTGCCCATTAA-3'
[0069] HPV-7:5'-TGTCGCTTAATTGCTCRTGAC-3'
[0070] HPV-8:5'-CCTCCCACACCACGGACACACAAAGGACAGTGGGAGG-3'
[0071] HPV-9:5'-GGACACAGCGCCCTGTCCAACG...
Embodiment 2
[0096] Example 2 A preferred embodiment of a kit for detecting HPV high-risk and intermediate-risk nucleic acid cellular levels of the present invention
[0097] The kit of this embodiment contains HPV double FAM-labeled probes, a fixative solution with a volume percent concentration of 4% paraformaldehyde, a volume percent concentration of 1% TritonX-100 permeation solution, a pre-hybridization solution, and a hybridization solution , wash solution and probes.
[0098] Wherein, the probes are probes for detecting high-risk and intermediate-risk HPV nucleic acids, and the probes have the sequences shown in SEQ ID NO: 1-28. The sequence shown in SEQ ID NO:1-28 is specifically as follows:
[0099] HPV-1:5'-ACGTGTTCTTGATGATCTGC-3'
[0100] HPV-2:5'-TAGAGATCAGTTGTCTCTGG-3'
[0101] HPV-3:5'-TGTAGAGTCACACTTRCAACA-3'
[0102] HPV-4:5'-TGTGTGCTTTGTACGCACAA-3'
[0103] HPV-5:5'-GGTCTTCCAAAGTACGAATG-3'
[0104] HPV-6:5'-ATTCCTAGTGTGCCCATTAA-3'
[0105] HPV-7:5'-TGTCGCTTAATTGCTCR...
Embodiment 3
[0131] Embodiment 3: detect one of high-risk HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 58, 59, 68 and intermediate-risk HPV26, 82 genotypes with the kit in Example 1 preferred embodiment
[0132] The probe in the kit in Example 1 is an HPV-27 probe, and the kit in Example 2 is used in this example to detect high-risk HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 58, 59, 68 and intermediate-risk HPV26, 82 genotypes. The specific experimental method is as follows:
[0133] Biotin-labeled HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 58, 59, 68, 26, 82 mRNA were respectively transcribed in vitro. After purification, 100 ng of mRNA was added to the streptavidin-labeled microspheres washed in the pre-hybridization solution. For the negative control, 1 μl of pure water was added to the streptavidin-labeled microspheres washed in the prehybridization solution. Add 5 μl of HPV-27 probe with a concentration of 0.5 μM to each group, make up to 10 μl with pre-hybridization solution, and mix well. Th...
PUM
| Property | Measurement | Unit |
|---|---|---|
| percent by volume | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


